INTRODUCTION
Salivary gland tumors represent an important group of neoplasms occurring in the mouth being more frequently seen in major salivary glands. Minor salivary gland tumors (MSGTs) correspond from 9% to 23% of all salivary gland tumors (1) (2) (3) (4) . Despite their low frequency and distinct biological behavior, MSGTs attract special attention due to their morphological diversity, a fact that renders their complex diagnosis (5) . Several series of salivary gland tumors have been published worldwide and they have demonstrated geographic and ethnic variations in their frequency and distribution (1) (2) (3) (4) (5) . In the English literature, studies about surveys of minor salivary gland tumors in South America are scarce and only three reports investigating this subject are available, being the last one reported in 1999 (6) . The aim of the present study was to review the clinical-epidemiological profile of MSGTs diagnosed in a South American population. In addition, data obtained were compared to the findings of similar studies. of life, respectively (Figure 1 ). In the group of malignant tumors, the peak of occurrence of the tumor was observed in the 6 th decade of life for male patients and in the 7 th and the 8 th decades for female patients ( Figure 2 ). A significant difference of the mean age between genders was observed in the group of benign tumors (p<0.05, Mann-whitney test), but not in the group of malignant tumors (p> 0.05, Mann-whitney test). The hard palate was most affected site by benign and malignant tumors (55.8%), followed by the soft palate (13.4%), the buccal mucosa (7.8%), and the lips (7%). Separate analysis of each site showed that tumors in the soft palate, buccal mucosa, tongue, floor of the mouth, alveolar mucosa, and retromolar region were predominantly malignant. On the other hand, tumors affecting the hard palate and upper lip were benign in most cases. Higher frequency of benign tumors was observed in the upper lip, whereas malignant tumors were more frequent in the tongue. This association was statistically significant (p< 0.05 and p< 0.05, respectively; binomial test). with respect to possible risk factors for the development of MSGTs, 22% of the patients with malignant tumors were smokers, 13% were alcoholics, and 5% had a family history of cancer. Fifty-eight of 217 patients with MSGTs wore dentures. Regarding the time of evolution of the tumor, malignant lesions presented a quicker clinical progression when compared to benign ones. Benign tumors presented a time of evolution of less than 12 months in 35.3% of cases, whereas the duration of malignant tumors, until the time of diagnosis, was less than six months in 22.9%. Comparison of benign and malignant tumors with a time of evolution of less than six months showed a significantly longer duration for benign tumors (p<0.05, Fisher's test). This also occurred with a time of duration longer than one year. The mean size of both benign and malignant MSGTs, considering their maximum diameter, was 2.78 cm (range: 0.4 to 6 cm) and 2.27 cm (range: 0.4 to 9.5 cm), respectively. The presence of a nodule (62.2%) was the main clinical feature of the MSGTs studied. Pain was reported by 20.3% of patients and ulceration detected in 9.2% of them. However, the presence of pain (27.1%) and ulceration (12.2%) was more frequent among malignant tumors when compared to benign ones. Pleomorphic adenomas (37.8%) and adenoid cystic carcinomas (15.6%) were the most frequent tumors among the MSGTs studied. Pleomorphic adenoma was the most common benign tumor, accounting for 83% of all benign tumors, followed by myoepithelioma, which was observed in 10% of cases. In addition, adenoid cystic carcinoma was the most common malignant tumor (28.8%), followed by mucoepidermoid carcinoma (13.4%) and non-specified adenocarcinoma (12.9%). with respect to treatment, all benign tumors were surgically removed. In the group of malignant tumors, surgery was the treatment of choice in 65.2% of cases, surgery combined with radiotherapy was applied in 31.4% of cases, and surgery combined with radiotherapy and chemotherapy was carried out in four lesions. Among the 217 MSGTs treated, the recurrence rate was 16.2%, including 11.2% of benign tumors and 20.4% of malignant tumors. Among malignant tumors, adenoid cystic carcinomas and mucoepidermoid carcinomas were the most frequent recurrent ones. with respect to the type of previous treatment of the recurrent malignant tumors, it was significantly more frequent in patients treated by surgery in combination with radiotherapy or chemotherapy than in those submitted to surgery only (p<0.05, Fisher's test).
DISCUSSION
Our results showed that the malignant tumors were the most commonly lesions diagnosed among MSGTs, being adenoid cystic carcinoma the most prevalent malignant tumor. High frequency of adenoid cystic carcinomas was consistent with the data previously presented (1, (8) (9) (10) . It is possible that high percentage of malignant tumors observed in the present study might be related to the fact that the institution where this study was carried out is a referral center for the treatment of cancer. However, there is still lack of agreement regarding the most frequent type of malignant MSGT. In studies carried out in India, Libya, The United Kingdom, Venezuela, and The United States of America (11) (12) (13) (14) (15) , the mucoepidermoid carcinoma was the most prevalent lesion. with respect to benign tumors, pleomorphic adenoma comprised 37,8 % of all MSGTs, which indicates a frequency comparable to other series (9, (13) (14) (15) . Patients with malignant tumors were, on average, 10 years older than those with benign tumors. In contrast, Jansisyanont et al. (16) observed that patients with malignant tumors were six years younger than those presenting benign tumors. In general, female patients were more affected, which is in line to previous studies (1, 8, 12, 14, 15, 17, 18) , although some authors report that malignant tumors are more common in men (6, 10, 19) . MGSTs are common in the palate, mainly in the hard palate, followed by the soft palate, buccal mucosa and lips (8, (14) (15) (16) (17) (18) 20) . In our study, the hard palate was more involved than the soft palate, and surprisingly, 55% of the tumors located in this site were malignant. Furthermore, in agreement with other authors (5), our study showed that the upper lip was more frequently affected by benign tumors. Some histological types of salivary gland tumors have shown a marked preference for specific anatomical sites. Loyola et al. (18) reported that cystadenomas are preponderantly encountered in the palate and lips whereas Pires et al. (20) found that these lesions occur more frequently in the lower lip. In addition, Yih et al. (5) observed that 64% of canalicular adenomas are located in the upper lip. In agreement with Buchner et al. (15) in the present study, cystadenomas were located in the buccal mucosa and tongue, and the only case of canalicular adenoma affected the upper lip. Interestingly, we identified that all tumors located in the floor of the mouth, and retromolar area were malignant lesions (9, 12) . In the present series, most benign tumors presented a time of duration of more than one year, whereas the time of duration of malignant tumors, until the time of diagnosis, was less than six months, with this difference being significant. These findings agree with those reported by Jansisyanont et al. (16) who observed that malignant tumors progressed faster than benign tumors, and by Lopes et al. (6) who found that the mean time of duration of malignant tumors was half that of benign ones. Other authors as Loyola et al. (18) reported a long mean duration of symptoms: 91.7 months for benign tumors and 28.6 months for malignant tumors. However, these findings differ from those reported by Jaber (12) who observed no significant differences in time of duration between benign and malignant tumors. On the other hand, Otoh et al. (21) showed a longer duration of malignant tumors, with a mean of 72.4 months. This study showed that the mean diameter of the lesions studied was 2.78 cm (SD=1.6) for benign tumors and 2.27 cm (SD=1.87) for malignant tumors. Similar findings were reported by Perez et al. (22) who observed a larger diameter for benign tumors (3.4 cm) compared to malignant ones (2.9 cm). However, our results differ from the series of Loyola et al. (18) and Yih et al. (5) who found a more marked growth for malignant neoplasms. According to the literature, we showed that clinical symptoms as a nodule, was frequent in more than 60% of cases (6, 12, 16) . Other features as pain and ulceration were more frequently reported by patients with malignant tumors, which is in agreement with previous reports (12, 18) . In the present series, all benign tumors were treated surgically, whereas in the group of malignant tumors, 34.8% were submitted to adjuvant postoperative radiotherapy. Similar results were reported by Lopes et al. (6) , in which 55.6% of 196 patients with MSGTs only underwent surgery and 30.2% were submitted to surgery followed by radiotherapy. Postoperative radiotherapy improves local control and the survival rate of patients with tumors that present a high degree of malignancy, compromised surgical margins or perineural invasion. However, radiotherapy should be indicated with caution, taking into account prognostic factors such as location of the tumor, clinical stage, histological type and the presence of compromised surgical margins (23, 24) . According to Mucke et al. (25) , radiation should be used for patients with higher stage tumors or bad prognostic factors, and as a therapy for patients showing recurrence. with respect to chemotherapy, its role in the treatment of salivary gland tumors remains uncertain (26) . In the present study, recurrence was observed in 16.2% of the 217 MSGTs, with 11.2% of benign tumors and 20.4% of malignant ones. Furthermore, we observed that patients with recurrent malignant tumors treated by surgery combined with radiotherapy and/or chemotherapy relapsed more frequently than those submitted to surgery only, with this difference being significant. It is possible that the recurrence rate observed in patients submitted to adjuvant radiotherapy and/or chemotherapy might be intrinsically related to prognostic factors of these tumors and does not necessarily predict failures in the treatment method. Finally, despite discrete variations in the distribution and frequency of some of the tumors studied when compared to other series, the results of our investigation are similar to those reported in other retrospective studies ( Table 2) . In this respect, some authors suggest that the frequency and distribution of salivary gland tumors are susceptible to ethnic and geographic variations (3, 16, 19) . Therefore, to the best of our knowledge, this study involves the largest series of MSGTs described in the South American population. The age range and the gender ratio were similar to the ones reported in other series, and the overall recurrence of 16.2% was within the reported range. However, this population showed a relatively higher proportion of malignant tumors, and these tumors were associated with a higher rate of recurrence when compared to benign tumors.
